CAMBRIDGE -
The Company anticipates he will make a full recovery and return to his role full-time in
About
Contact:
Tel: 617-949-4256
Email: Jeff.Boyle@sagerx.com
(C) 2020 Electronic News Publishing, source
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.58 USD | -3.00% | +4.18% | -37.33% |
Apr. 25 | Truist Securities Cuts Sage Therapeutics' Price Target to $18 From $22, Hold Rating Maintained | MT |
Apr. 25 | Transcript : Sage Therapeutics, Inc., Q1 2024 Earnings Call, Apr 25, 2024 |
CAMBRIDGE -
The Company anticipates he will make a full recovery and return to his role full-time in
About
Contact:
Tel: 617-949-4256
Email: Jeff.Boyle@sagerx.com
(C) 2020 Electronic News Publishing, source
1st Jan change | Capi. | |
---|---|---|
-37.33% | 817M | |
-2.26% | 103B | |
+1.41% | 95.71B | |
+0.79% | 22.02B | |
-17.84% | 20.9B | |
-11.11% | 17.85B | |
-42.83% | 16.21B | |
-17.63% | 15.52B | |
+4.55% | 13.86B | |
+32.11% | 12.04B |